SP Industries, Inc. (SP), a leading designer and manufacturer of state-of-the-art laboratory equipment, biological drug manufacturing solutions, and specialty glassware, has announced that it has acquired privately held Bel-Art Products (Bel-Art). Headquartered in Wayne (NJ, USA), Bel-Art is a global provider of innovative laboratory solutions serving the scientific, industrial, and healthcare end markets. 

Automated solution unlocks the power of clinical data and accelerates LC-MS/MS workflows.

Novel program increases lab accuracy and unknown compound identification with single quadrupole instrumentation.

Instrument driver exchange enhances laboratory efficiency, flexibility.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) received a Silver Telly Award, the highest honor, in the category Branded Content, Commercials, for its commercial “Bio-Rad iScript Supermix vs.Brand X”. The 35th Annual Telly Awards were announced June 16. Bio-Rad’s winning commercial compared its iScript™ Reverse Transcription Supermix for RT-qPCR to a product from a leading competitor. This year there were nearly 12,000 entries for Telly Awards from all 50 states and numerous countries. This is the second Silver Telly Award Bio-Rad has won in two years

Merck Millipore, the Life Science division of Merck, today (June 17) launched Simplicon™ RNA Reprogramming Technology, which uses synthetic self-replicating RNA to create large numbers of human induced pluripotent stem cells (iPSCs) using a single transfection step. This efficient reprogramming of somatic cells is accomplished without viral intermediates or host genome integration, offering a more defined and safer system for iPSC generation.

Study to form part of a “Science behind the World Cup” special feature.

Scientists at Thermo Fisher Scientific and BioAnalytix, Inc., of Cambridge, MA, are combining their expertise to develop advanced analytical profiling platforms and applications to characterize biologic and biosimilar drugs.

John Wiley & Sons, Inc., a global provider of knowledge and knowledge-enabled solutions that improve outcomes in research, professional practice, and education, announced today that it has acquired SimBioSys Inc., a provider of scientific software tools that facilitate the drug discovery process. Terms were not disclosed.

Integrated DNA Technologies fuses fruit flies, football and fun in a unique global contest with great prizes.